Health
23andMe’s breast cancer test may create false sense of security
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?
News
Advertisement
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?
Among men, half of the risk associated with smoking a pack of 20 comes from just the first cigarette